Dr.Ergo® L-Ergothioneine: FDA GRAS Notice GRN 001191 and Its Scope
Dr.Ergo® is the L-ergothioneine ingredient brand of Shanghai EGT Synbio Group Co., Ltd. This update explains the public regulatory record buyers can review when qualifying the ingredient.
What does GRN 001191 confirm?
In its January 30, 2025 response to GRN 001191, the U.S. FDA reported no questions regarding Shanghai EGT Synbio Group's GRAS conclusion for ergothioneine under the notified conditions of use. The letter is not an FDA product approval or a blanket authorization for every formulation.
The notified uses cover specified food categories at 5 mg per serving, including cakes, cookies, pastries, granola bars, coffee, tea, fruit drinks, carbonated soft drinks and candy containing chocolate. The letter describes a purity specification of ≥99.9%. It does not establish a recommended daily intake of 560 mg for adults or authorize health claims.
Read the original FDA response letter for GRN 001191 (PDF) for the complete ingredient identity, manufacturing description, intended uses and limitations.
Documents for ingredient qualification
A regulatory response, a product specification and a batch certificate of analysis answer different purchasing questions. Review them together for the exact grade being ordered.
- Specification: the provided food-grade Dr.Ergo® document identifies L-ergothioneine, CAS 497-30-3, with an assay limit of ≥99.9% using an HPLC external-standard method. Download the food-grade specification (Chinese PDF).
- Batch CoA: match the lot number, test methods, specification limits and measured results to the material supplied. A specification limit is not the measured result of every batch.
- Certificates: check the holder, covered product or production scope, and expiry date for the grade and facility involved. View the quality information.
- Application review: identify the target market, food category and proposed use level before selecting the documentation needed for the finished product.
Purchasing questions
Does the response apply to every Dr.Ergo® application?
Use the notice's defined scope as the starting point. Ask the supplier to match the offered grade and intended application to the relevant documents, rather than treating a notice number as a specification for all products.
What should a document request include?
Include the ingredient and grade, intended application, destination market, quantity, required tests and any certificate requirements. Request the current specification and a batch-specific CoA before confirming a purchase.
Request Dr.Ergo® specifications and batch quality documents.
Editorial update: November 12, 2026. The original news date is retained; regulatory wording and document links have been clarified against the original FDA letter.